The effectiveness of lifestyle interventions to reduce cardiovascular risk in patients with severe mental disorders: Meta-analysis of intervention studies

Community Mental Health Journal

Volumn 50, Issue 1, 2014, Pages 81-95

  Fernández San Martín, Maria Isabel ^a   Martín López, Luis Miguel ^b   Masa Font, Roser ^a   Olona Tabueña, Noemí ^a   Roman, Yuani ^a   Martin Royo, Jaume ^a   Oller Canet, Silvia ^a   González Tejón, Susana ^a   San Emeterio, Luisa ^a   Barroso Garcia, Albert ^a   Viñas Cabrera, Lidia ^a   Flores Mateo, Gemma ^a  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

Exercise; Food Habits; Life Style; Psychotic Disorders; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BODY MASS; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; COMORBIDITY; FEMALE; HUMAN; LIFESTYLE; MALE; META ANALYSIS; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SCHIZOPHRENIA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SCHIZOPHRENIA;

EID: 84895058265     PISSN: 00103853     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10597-013-9614-6     Document Type: Article

References (42)

1. Álvarez-Jiménez, M.; González-Blanch, C.; Vázquez-Barquero, J. L.; Pérez-Iglesias, R.; Martínez- García, O.; Pérez-Pardal, T.; et al. (2006). Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial. Journal of Clinical Psychiatry, 67, 1253-1260.
2. Alvarez-Jiménez, M.; Hetrick, S. E.; González-Blanch, C.; Gleeson, J. F.; McGorry, P. D. (2008). Non-pharmacological management of antipsychotic-induced weight gain: Systematic review and meta-analysis of randomised controlled trials. British Journal of Psychiatry, 193(2), 101-107.
3. Ball, M. P.; Coons, V. B.; Buchanan, R. W. (2001). A program for treating olanzapine-related weight gain. Psychiatric Services (Washington, D. C.), 52(7), 967-969.
4. Beebe, L. H.; Tian, L.; Morris, N.; Goodwin, A.; Allen, S. S.; Kuldau, J. (2005). Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues in Mental Health Nursing, 26(6), 661-676.
5. Blouin, M.; Binet, M.; Bouchard, R. H.; Roy, M. A.; Després, J. P.; Alméras, N. (2009). Improvement of metabolic risk profile under second-generation antipsychotics: A pilot intervention study. Canadian Journal of Psychiatry, 54(4), 275-279.
6. Brar, J. S.; Ganguli, R.; Pandina, G.; Turkoz, I.; Berry, S.; Mahmoud, R. (2005). Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychiatry, 66(2), 205-212.
7. Centorrino, F.; Wurtman, J. J.; Duca, K. A.; Fellman, V. H.; Fogarty, K. V.; Berry, J. M.; et al. (2006). Weight loss in overweight patients maintained on atypical antipsychotic agents. International Journal of Obesity (London), 30(6), 1011-1016.
8. Colton, C. W.; Manderscheid, R. W. (2006). Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Disease, 3(2), A42.
9. De Hert, M.; Dekker, J. M.; Wood, D.; Kahl, K. G.; Holt, R. I.; Möller, H. J. (2009). Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry, 24(6), 412-424.
10. Evans, S.; Newton, R.; Higgins, S. (2005). Nutritional intervention to prevent weight gain in patients commenced on olanzapine: A randomized controlled trial. Australian and New Zealand Journal of Psychiatry, 39(6), 479-486.
11. Faulkner, G.; Cohn, T.; Remington, G. (2007). Interventions to reduce weight gain in schizophrenia. Cochrane Database Systematic Review, 24(1), CD005148.
12. Forsberg, K. A.; Björkman, T.; Sandman, P. O.; Sandlund, M. (2008). Physical health - a cluster randomized controlled lifestyle intervention among persons with a psychiatric disability and their staff. Nordic Journal of Psychiatry, 62(6), 486-495.
13. Generalitat de Catalunya. (2003). Programa d'atenció Especifica als Trastorns Mentals Severs. Barcelona: Generalitat de Catalunya, Departament de Sanitat i Seguretat Social.
14. Goff, C.; Cather, C.; Evins, A. E.; Henderson, D. C.; Freudenreich, O.; Copeland, P. M.; et al. (2005). Medical morbidity and mortality in schizophrenia: Guidelines for psychiatrists. Journal of Clinical Psychiatry, 66(2), 183-194.
15. Grundy, S. M.; Cleeman, J. I.; Daniels, S. R.; Donato, K. A.; Eckel, R. H.; Franklin, B. A.; et al. (2005). American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112, 2735-2752.
16. Higgins, J. P. T.; Green, S. (Eds.) (2011). Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org.
17. Higgins, J. P.; Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21(11), 1539-1558.
18. Iglesias-Garcia, C.; Toimil-Iglesias, A.; Alonso-Villa, M. J. (2010). Pilot study of the efficacy of an educational programme to reduce weight, on overweight and obese patients with chronic stable schizophrenia. Journal of Psychiatric and Mental Health Nursing, 17, 849-851.
19. Jean-Baptiste, M.; Tek, C.; Liskov, E.; Chakunta, U. R.; Nicholls, S.; Hassan, A. Q.; et al. (2007). A pilot study of a weight management program with food provision in schizophrenia. Schizophrenia Research, 96(1-3), 198-205.
20. Kwon, J. S.; Choi, J. S.; Bahk, W. M.; Kim, C. Y.; Kim, C. H.; Shin, Y. C.; et al. (2006). Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. Journal of Clinical Psychiatry, 67, 547-553.
21. Littrell, K. H.; Hilligoss, N. M.; Kirshner, C. D.; Petty, R. G.; Johnson, C. G. (2003). The effects of an educational intervention on antipsychotic-induced weight gain. Journal of Nursing Scholarship, 35(3), 237-241.
22. Marrugat, J.; Solanas, P.; D'Agostino, R.; Sullivan, L.; Ordovas, J.; Cordón, F.; et al. (2003). Coronary risk estimation in Spain using a calibrated Framingham function. Revista Espanola de Cardiologia, 56(3), 253-261.
23. Marzolini, S.; Jensen, B.; Melville, P. (2009). Feasibility and effects of a group-based resistance and aerobic exercise program for individuals with severe schizophrenia: A multidisciplinary approach. Mental Health and Physical Activity, 2, 29-36.
24. May, H. J.; Gazda, G. M.; Powell, M.; Hauser, G. (1985). Life skill training: Psychoeducational training as mental health treatment. Journal of Clinical Psychology, 41(3), 359-367.
25. McCreadie, R. G.; Kelly, C.; Connolly, M.; Williams, S.; Baxter, G.; Lean, M.; et al. (2005). Dietary improvement in people with schizophrenia: Randomised controlled trial. British Journal of Psychiatry, 187, 346-351.
26. McEvoy, J. P.; Meyer, J. M.; Goff, D. C.; Nasrallah, H. A.; Davis, S. M.; Sullivan, L.; et al. (2005). Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research, 80(1), 19-32.
27. McKibbin, C. L.; Golshan, S.; Griver, K.; Kitchen, K.; Wykes, T. L. (2010). A healthy lifestyle intervention for middle-aged and older schizophrenia patients with diabetes mellitus: A 6-month follow-up analysis. Schizophrenia Research, 121(1-3), 203-206.
28. McKibbin, C. L.; Patterson, T. L.; Norman, G.; Patrick, K.; Jin, H.; Roesch, S.; et al. (2006). A lifestyle intervention for older schizophrenia patients with diabetes mellitus: A randomized controlled trial. Schizophrenia Research, 86(1-3), 36-44.
29. Melamed, Y.; Stein-Reisner, O.; Gelkopf, M.; Levi, G.; Sivan, T.; Ilievici, G.; et al. (2008). Multi-modal weight control intervention for people with persistent mental disorders. Psychiatric Rehabilitation Journal, 31(3), 194-200.
30. Menza, M.; Vreeland, B.; Minsky, S.; Gara, M.; Radler, D. R.; Sakowitz, M. (2004). Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. Journal of Clinical Psychiatry, 65(4), 471-477.
31. Perälä, J.; Suvisaari, J.; Saarni, S. I.; Kuoppasalmi, K.; Isometsä, E.; Pirkola, S.; et al. (2007). Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of General Psychiatry, 64, 19-28.
32. Porsdal, V.; Beal, C.; Kleivenes, O. K.; Martinsen, E. W.; Lindström, E.; Nilsson, H.; et al. (2010). The Scandinavian solutions for wellness study - a two-arm observational study on the effectiveness of lifestyle intervention on subjective well-being and weight among persons with psychiatric disorders. BMC Psychiatry, 10, 42.
33. Poulin, M. J.; Chaput, J. P.; Simard, V.; Vincent, P.; Bernier, J.; Gauthier, Y.; et al. (2007). Management of antipsychotic-induced weight gain: Prospective naturalistic study of the effectiveness of a supervised exercise programme. Australian and New Zealand Journal of Psychiatry, 41(12), 980-989.
34. Scocco, P.; Longo, R.; Caon, F. (2006). Weight change in treatment with olanzapine and a psychoeducational approach. Eating Behaviors, 7(2), 115-124.
35. SEMERGEN Doc. Factores de Riesgo Cardiovascular. (2005). Available from http://www.semergen.es/semergen/microsites/semergendoc/factores-cardiov/ doc-complet.pdf.
36. Skrinar, G. S.; Huxley, N. A.; Hutchinson, D. S.; Menninger, E.; Glew, P. (2005). The role of a fitness intervention on people with serious psychiatric disabilities. Psychiatric Rehabilitation Journal, 29(2), 122-127.
37. Van Citters, A. D.; Pratt, S. I.; Jue, K.; Williams, G.; Miller, P. T.; Xie, H.; et al. (2010). A pilot evaluation of the In SHAPE individualized health promotion intervention for adults with mental illness. Community Mental Health Journal, 46, 540-552.
38. Veit, T.; Barnas, C. (2009). Diet blues: Methodological problems in comparing non-pharmacological weight management programs for patients with schizophrenia. International Journal of Psychiatry in Clinical Practice, 13(3), 173-183.
39. Vreeland, B.; Minsky, S.; Menza, M.; Rigassio Radler, D.; Roemheld-Hamm, B.; Stern, R. (2003). A program for managing weight gain associated with atypical antipsychotics. Psychiatric Services (Washington, D. C.), 54(8), 1155-1157.
40. Weber, M.; Wyne, K. (2006). A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophrenia Research, 83(1), 95-101.
41. Wu, M. K.; Wang, C. K.; Bai, Y. M.; Huang, C. Y.; Lee, S. D. (2007). Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatric Services (Washington, D. C.), 58(4), 544-550.
42. Wu, R. R.; Zhao, J. P.; Jin, H.; Shao, P.; Fang, M. S.; Guo, X. F.; et al. (2008). Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA, 299(2), 185-193.